In ET, patients with CALR mutations showed male predominance, higher platelet counts, lower hemoglobin levels and leukocyte counts, and a lower risk of thrombosis than patients with JAK2 and MPL mutations [4]. This evidence concerns the gene JAK2 and essential thrombocythemia.